Stay updated on CD101 vs Caspofungin in Candidemia Clinical Trial
Sign up to get notified when there's something new on the CD101 vs Caspofungin in Candidemia Clinical Trial page.

Latest updates to the CD101 vs Caspofungin in Candidemia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe NIH banner announcing a transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs is no longer displayed. The page still shows a 403 Forbidden error.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check52 days agoChange DetectedThe 403 Forbidden error markup and the associated Home link were removed from the page, removing the error-state content and its navigation element.SummaryDifference0.5%

Stay in the know with updates to CD101 vs Caspofungin in Candidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD101 vs Caspofungin in Candidemia Clinical Trial page.